FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Daniel Diekema

Research Profile

Procedures

Chemicals & Drugs

Living Beings

Physiology

Disorders

Geographic Areas

Co-author Network

Publications

TOP 3
Daniel J Diekema; Michael A Pfaller
Rapid detection of antibiotic-resistant organism carriage for infection prevention.
Jennifer S McDanel; Courtney R Murphy; Ellena M Peterson; Victor Quan; Grace L Tan; Daniel J Diekema; Kaye D Evans; Mary K Hayden; Diane S Kim; Susan S Huang
Chlorhexidine and mupirocin susceptibilities of methicillin-resistant staphylococcus aureus from colonized nursing home residents.
Susan E Beekmann; John M Boyce; Daniel J Diekema; Loreen Herwaldt; W Charles Huskins; Philip M Polgreen; Robert J Sherertz
Diagnosing and reporting of central line-associated bloodstream infections.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Daniel Diekema (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Daniel J Diekema; Michael A Pfaller
Rapid detection of antibiotic-resistant organism carriage for infection prevention.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013;56(11):1614-20.
2013: Jennifer S McDanel; Courtney R Murphy; Ellena M Peterson; Victor Quan; Grace L Tan; Daniel J Diekema; Kaye D Evans; Mary K Hayden; Diane S Kim; Susan S Huang
Chlorhexidine and mupirocin susceptibilities of methicillin-resistant staphylococcus aureus from colonized nursing home residents.
Antimicrobial agents and chemotherapy 2013;57(1):552-8.
2012: Susan E Beekmann; John M Boyce; Daniel J Diekema; Loreen Herwaldt; W Charles Huskins; Philip M Polgreen; Robert J Sherertz
Diagnosing and reporting of central line-associated bloodstream infections.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2012;33(9):875-82.
2012: Michael A Pfaller; V Chaturvedi; Daniel J Diekema; Mahmoud A Ghannoum; N M Holliday; Scott B Killian; Cindy C Knapp; Shawn A Messer; A Miskou; R Ramani
Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff values.
Diagnostic microbiology and infectious disease 2012;73(4):365-8.
2012: Birgir Johannsson; Sarah J Johnson; Susan E Beekmann; Daniel J Diekema; Erika J Ernst; Loreen Herwaldt; Philip M Polgreen
Antimicrobial therapy for bloodstream infection due to methicillin-susceptible Staphylococcus aureus in an era of increasing methicillin resistance: opportunities for antimicrobial stewardship.
The Annals of pharmacotherapy 2012;46(6):904-5.
2012: Gary V Doern; Cassie L Dohrn; Kristopher P Heilmann; Fathollah Riahi; Daniel J Diekema; Sandra S Richter
In vitro activity of ceftaroline against clinical isolates of Streptococcus pneumoniae recovered in 43 U.S. medical centers during 2010-2011.
Antimicrobial agents and chemotherapy 2012;56(6):3406-8.
2012: Sara E Cosgrove; Daniel J Diekema; Vidhya Gunaseelan; Loreen A Herwaldt; Gary A Noskin; Trish M Perl; Susan K Seo; Kent A Sepkowitz; Kathleen Speck; Edward Wong; Maureen K Bolon; Michael W Climo
Evaluation of postprescription review and feedback as a method of promoting rational antimicrobial use: a multicenter intervention.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2012;33(4):374-80.
2012: Jeremy C Storm; Daniel J Diekema; Sarah J Johnson; Jennifer S Kroeger; Birgir Johannsson
Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus.
Antimicrobial resistance and infection control 2012;1(1):19.
2011: Michael A Pfaller; Barbara D Alexander; David Andes; Maiken C Arendrup; Steven D Brown; Vishnu Chaturvedi; Daniel J Diekema; Ana Espinel-Ingroff; Cynthia L Fowler; Mahmoud A Ghannoum; Elizabeth M Johnson; Cynthia C Knapp; Mary R Motyl; Luis Ostrosky-Zeichner; THOMAS WALSH
Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria.
Diagnostic microbiology and infectious disease 2011;70(3):330-43.
2011: Hsiu-yin Chiang; Victoria M Steelman; Jean M Pottinger; Annette J Schlueter; Daniel J Diekema; Jeremy D W Greenlee; Matthew A Howard; Loreen A Herwaldt
Clinical significance of positive cranial bone flap cultures and associated risk of surgical site infection after craniotomies or craniectomies.
Journal of neurosurgery 2011;114(6):1746-54.
2011: Michael A Pfaller; D Andes; M C Arendrup; S D Brown; Daniel J Diekema; S R Lockhart; M Motyl; D S Perlin
Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2011;14(3):164-76.
2011: Michael A Pfaller; L B Boyken; Richard J Hollis; J Kroeger; Shawn A Messer; Shailesh Tendolkar; Daniel J Diekema
Validation of 24-hour posaconazole and voriconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: application of epidemiological cutoff values to results from a global Candida antifungal surveillance program.
Journal of clinical microbiology 2011;49(4):1274-9.
2011: Michael A Pfaller; Ana Espinel-Ingroff; Linda Boyken; Richard J Hollis; J Kroeger; Shawn A Messer; Shailesh Tendolkar; Daniel J Diekema
Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing with the 24-hour CLSI BMD method for testing susceptibility of Candida species to fluconazole, posaconazole, and voriconazole by use of epidemiological cutoff values.
Journal of clinical microbiology 2011;49(3):845-50.
2011: Michael A Pfaller; Linda Boyken; Richard J Hollis; J Kroeger; Shawn A Messer; Shailesh Tendolkar; Daniel J Diekema
Wild-type MIC distributions and epidemiological cutoff values for posaconazole and voriconazole and Candida spp. as determined by 24-hour CLSI broth microdilution.
Journal of clinical microbiology 2011;49(2):630-7.
2011: Kerry R Leedom Larson; Abby L Harper; Blake M Hanson; Michael J Male; Shylo E Wardyn; Anne E Dressler; Elizabeth A Wagstrom; Shaliesh Tendolkar; Daniel J Diekema; Kelley J Donham; Tara C Smith
Methicillin-resistant Staphylococcus aureus in pork production shower facilities.
Applied and environmental microbiology 2011;77(2):696-8.
2010: Michael A Pfaller; Daniel J Diekema; DL Gibbs; VA Newell; Richard Barton; Hu Bijie; Jacques Bille; Shan-Chwen Chang; Maria da Luz Martins; Adriano Duse; Danuta Dzierzanowska; David Ellis; Jorge Finquelievich; Ian Gould; Deniz Gur; Anwar Hoosen; Kyungwon Lee; Nada Mallatova; Michele Mallie; N G Kee Peng; George Petrikos; Axel Santiago; Jan Trupl; Ann Marie VanDen Abeele; Jeannette Wadula; Mussaret Zaidi
Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program.
Diagnostic microbiology and infectious disease 2010;67(2):162-71.
2010: Michael A Pfaller; M Castanheira; Daniel J Diekema; Shawn A Messer; G J Moet; Ronald Jones
Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species.
Journal of clinical microbiology 2010;48(5):1592-9.
2010: Philip M Polgreen; Susan E Beekmann; Daniel J Diekema; Robert J Sherertz
Wide variability in the use of antimicrobial lock therapy and prophylaxis among infectious diseases consultants.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2010;31(5):554-7.
2010: Michael A Pfaller; Linda Boyken; Richard J Hollis; Jennifer Kroeger; Shawn A Messer; Shailesh Tendolkar; Daniel J Diekema
Wild-type minimum effective concentration distributions and epidemiologic cutoff values for caspofungin and Aspergillus spp. as determined by Clinical and Laboratory Standards Institute broth microdilution methods.
Diagnostic microbiology and infectious disease 2010;67(1):56-60.
2010: Michael A Pfaller; Daniel J Diekema; DL Gibbs; VA Newell; D Ellis; V Tullio; A Rodloff; W Fu; T A Ling
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion.
Journal of clinical microbiology 2010;48(4):1366-77.
2010: Michael A Pfaller; Daniel J Diekema
Epidemiology of invasive mycoses in North America.
Critical reviews in microbiology 2010;36(1):1-53.
2010: Michael A Pfaller; Linda Boyken; Richard J Hollis; J Kroeger; Shawn A Messer; Shailesh Tendolkar; Ronald Jones; J Turnidge; Daniel J Diekema
Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp.
Journal of clinical microbiology 2010;48(1):52-6.
2009: Michael A Pfaller; Shawn A Messer; N Georgopapadakou; L A Martell; J M Besterman; Daniel J Diekema
Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogens.
Journal of clinical microbiology 2009;47(12):3797-804.
2009: Janet I Andrews; Diedre K Fleener; Shawn A Messer; Jennifer S Kroeger; Daniel J Diekema
Screening for Staphylococcus aureus carriage in pregnancy: usefulness of novel sampling and culture strategies.
American journal of obstetrics and gynecology 2009;201(4):396.e1-5.
2009: Daniel J Diekema; Shawn A Messer; L B Boyken; Richard J Hollis; J Kroeger; Shailesh Tendolkar; Michael A Pfaller
In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods.
Journal of clinical microbiology 2009;47(10):3170-7.
2009: Michael A Pfaller; Linda Boyken; Richard J Hollis; J Kroeger; Shawn A Messer; Shailesh Tendolkar; Daniel J Diekema
In vitro susceptibility of clinical isolates of Aspergillus spp. to anidulafungin, caspofungin, and micafungin: a head-to-head comparison using the CLSI M38-A2 broth microdilution method.
Journal of clinical microbiology 2009;47(10):3323-5.
2009: Michael A Pfaller; Daniel J Diekema; Mahmoud A Ghannoum; John H Rex; B D Alexander; D Andes; S D Brown; V Chaturvedi; Ana Espinel-Ingroff; C L Fowler; E M Johnson; Cindy C Knapp; M R Motyl; L Ostrosky-Zeichner; D J Sheehan; THOMAS WALSH
Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods.
Journal of clinical microbiology 2009;47(10):3142-6.
2009: Michael A Pfaller; Shawn A Messer; Richard J Hollis; Linda Boyken; Shailesh Tendolkar; J Kroeger; Daniel J Diekema
Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007.
Journal of clinical microbiology 2009;47(10):3185-90.
2009: Michael A Pfaller; Linda Boyken; Richard J Hollis; Jennifer Kroeger; Shawn A Messer; Shailesh Tendolkar; Daniel J Diekema
Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program.
Diagnostic microbiology and infectious disease 2009;65(1):27-34.
2009: Michael J Klevay; David L Horn; Dionissios Neofytos; Michael A Pfaller; Daniel J Diekema
Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection.
Diagnostic microbiology and infectious disease 2009;64(2):152-7.
2009: Daniel J Diekema; Shawn A Messer; Richard J Hollis; Linda Boyken; Shailesh Tendolkar; Jennifer Kroeger; Ronald N Jones; Michael A Pfaller
A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp.
Diagnostic microbiology and infectious disease 2009;63(2):233-6.
2009: Tara C Smith; Michael J Male; Abby L Harper; Jennifer S Kroeger; Gregory P Tinkler; Erin D Moritz; Ana W Capuano; Loreen A Herwaldt; Daniel J Diekema
Methicillin-resistant Staphylococcus aureus (MRSA) strain ST398 is present in midwestern U.S. swine and swine workers.
PloS one 2009;4(1):e4258.
2009: Shawn R Lockhart; Shawn A Messer; Michael A Pfaller; Daniel J Diekema
Identification and Susceptibility Profile of Candida fermentati from a worldwide collection of Candida guilliermondii clinical isolates.
Journal of clinical microbiology 2009;47(1):242-4.
2009: Michael A Pfaller; Daniel J Diekema; DL Gibbs; VA Newell; H Bijie; D Dzierzanowska; N N Klimko; V Letscher-Bru; M Lisalova; K Muehlethaler; C Rennison; M Zaidi
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
Journal of clinical microbiology 2009;47(1):117-23.
2008: Luis Ostrosky-Zeichner; John H Rex; Michael A Pfaller; Daniel J Diekema; Barbara D Alexander; David Andes; Steven D Brown; Vishnu Chaturvedi; Mahmoud A Ghannoum; Cindy C Knapp; Daniel J Sheehan; THOMAS WALSH
Rationale for reading fluconazole MICs at 24 hours rather than 48 hours when testing Candida spp. by the CLSI M27-A2 standard method.
Antimicrobial agents and chemotherapy 2008;52(11):4175-7.
2008: Michael A Pfaller; L B Boyken; Richard J Hollis; J Kroeger; Shawn A Messer; Shailesh Tendolkar; Daniel J Diekema
Validation of 24-hour fluconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: results from a global Candida antifungal surveillance program.
Journal of clinical microbiology 2008;46(11):3585-90.
2008: Janet I Andrews; Alireza Shamshirsaz; Daniel J Diekema
Nonmenstrual toxic shock syndrome due to methicillin-resistant Staphylococcus aureus.
Obstetrics and gynecology 2008;112(4):933-8.
2008: Lucy A Wibbenmeyer; G Patrick Kealey; Barbara A Latenser; Daniel J Diekema; Ingrid M Williams; Stacy L Coffman; Patricia L Winokur; Jennifer S Kroeger; Robert W Lewis; Loreen A Herwaldt
Emergence of the USA300 strain of methicillin-resistant Staphylococcus aureus in a burn-trauma unit.
Journal of burn care & research : official publication of the American Burn Association 2008;29(5):790-7.
2008: Lauren Wrobel; Julia K Whittington; Claude Pujol; Soon-Hwan Oh; Marilyn O Ruiz; Michael A Pfaller; Daniel J Diekema; David Soll; Lois L Hoyer
Molecular phylogenetic analysis of a geographically and temporally matched set of Candida albicans isolates from humans and nonmigratory wildlife in central Illinois.
Eukaryotic cell 2008;7(9):1475-86.
2008: Michael A Pfaller; Daniel J Diekema; L Ostrosky-Zeichner; John H Rex; B D Alexander; D Andes; S D Brown; V Chaturvedi; Mahmoud A Ghannoum; Cindy C Knapp; D J Sheehan; THOMAS WALSH
Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints.
Journal of clinical microbiology 2008;46(8):2620-9.
2008: Shawn R Lockhart; Shawn A Messer; Michael A Pfaller; Daniel J Diekema
Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis.
Journal of clinical microbiology 2008;46(8):2659-64.
2008: Michael A Pfaller; Shawn A Messer; Linda Boyken; Cassie Rice; Shailesh Tendolkar; Richard J Hollis; Daniel J Diekema
In vitro survey of triazole cross-resistance among more than 700 clinical isolates of Aspergillus species.
Journal of clinical microbiology 2008;46(8):2568-72.
2008: Michael A Pfaller; V Chaturvedi; Daniel J Diekema; Mahmoud A Ghannoum; N M Holliday; Scott B Killian; Cindy C Knapp; Shawn A Messer; A Miskov; R Ramani
Clinical evaluation of the Sensititre YeastOne colorimetric antifungal panel for antifungal susceptibility testing of the echinocandins anidulafungin, caspofungin, and micafungin.
Journal of clinical microbiology 2008;46(7):2155-9.
2008: Susan S Huang; Daniel J Diekema; David K Warren; Gianna Zuccotti; Patricia L Winokur; Shailesh Tendolkar; Linda Boyken; Rupak Datta; Rebecca M Jones; Melissa A Ward; Tanya Aubrey; Andrew B Onderdonk; Christian Garcia; Richard Platt
Strain-relatedness of methicillin-resistant Staphylococcus aureus isolates recovered from patients with repeated infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(8):1241-7.
2008: Daniel J Diekema; Michael Climo
Preventing MRSA infections: finding it is not enough.
JAMA : the journal of the American Medical Association 2008;299(10):1190-2.
2008: Michael A Pfaller; Daniel J Diekema; DL Gibbs; VA Newell; K P Ng; A Colombo; J Finquelievich; R Barnes; J Wadula
Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.
Journal of clinical microbiology 2008;46(3):842-9.
2008: Michael J Klevay; Erika J Ernst; Jesse L Hollanbaugh; Joshua G Miller; Michael A Pfaller; Daniel J Diekema
Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection.
Diagnostic microbiology and infectious disease 2008;60(3):273-7.
2008: Michael A Pfaller; Shawn A Messer; Linda Boyken; Shailesh Tendolkar; Richard J Hollis; Daniel J Diekema
Selection of a surrogate agent (fluconazole or voriconazole) for initial susceptibility testing of posaconazole against Candida spp.: results from a global antifungal surveillance program.
Journal of clinical microbiology 2008;46(2):551-9.
2008: Michael A Pfaller; Daniel J Diekema; DL Gibbs; VA Newell; E Nagy; S Dobiasova; M Rinaldi; R Barton; A Veselov
Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.
Journal of clinical microbiology 2008;46(2):515-21.
2008: Michael A Pfaller; Linda Boyken; Richard J Hollis; J Kroeger; Shawn A Messer; Shailesh Tendolkar; Daniel J Diekema
In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.
Journal of clinical microbiology 2008;46(1):150-6.
2008: Shawn R Lockhart; Shawn A Messer; Michael A Pfaller; Daniel J Diekema
Lodderomyces elongisporus masquerading as Candida parapsilosis as a cause of bloodstream infections.
Journal of clinical microbiology 2008;46(1):374-6.
2007: Michael A Pfaller; Daniel J Diekema; G W Procop; Michael G Rinaldi
Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp.
Journal of clinical microbiology 2007;45(11):3522-8.
2007: Janet I Andrews; Diedre K Fleener; Shawn A Messer; Wendy F Hansen; Michael A Pfaller; Daniel J Diekema
The yeast connection: is Candida linked to breastfeeding associated pain?
American journal of obstetrics and gynecology 2007;197(4):424.e1-4.
2007: Shawn R Lockhart; Murray A Abramson; Susan E Beekmann; Gale Gallagher; Stefan Riedel; Daniel J Diekema; John P Quinn; G V Doern
Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004.
Journal of clinical microbiology 2007;45(10):3352-9.
2007: Michael A Pfaller; Daniel J Diekema; DL Gibbs; VA Newell; Jacques Meis; I M Gould; W Fu; A L Colombo; E Rodriguez-Noriega
Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
Journal of clinical microbiology 2007;45(6):1735-45.
2007: Daniel J Diekema; Shawn A Messer; Richard J Hollis; Linda B Boyken; Shailesh Tendolkar; Jennifer Kroeger; Michael A Pfaller
Evaluation of Etest and disk diffusion methods compared with broth microdilution antifungal susceptibility testing of clinical isolates of Candida spp. against posaconazole.
Journal of clinical microbiology 2007;45(6):1974-7.
2007: Daniel J Diekema; Michael B Edmond
Look before you leap: active surveillance for multidrug-resistant organisms.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(8):1101-7.
2007: Shawn A Messer; Daniel J Diekema; Richard J Hollis; Linda B Boyken; Shailesh Tendolkar; Jennifer Kroeger; Michael A Pfaller
Evaluation of disk diffusion and Etest compared to broth microdilution for antifungal susceptibility testing of posaconazole against clinical isolates of filamentous fungi.
Journal of clinical microbiology 2007;45(4):1322-4.
2007: Michael A Pfaller; Daniel J Diekema; G W Procop; Michael G Rinaldi
Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida spp.
Journal of clinical microbiology 2007;45(3):796-802.
2007: Philip M Polgreen; Yi Yi Chen; Joseph E Cavanaugh; Melissa Ward; Stacy Coffman; Douglas B Hornick; Daniel J Diekema; Loreen A Herwaldt
An outbreak of severe Clostridium difficile-associated disease possibly related to inappropriate antimicrobial therapy for community-acquired pneumonia.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2007;28(2):212-4.
2007: Susan S Huang; Sheryl L Rifas-Shiman; Jean M Pottinger; Loreen A Herwaldt; Teresa R Zembower; Gary A Noskin; Sara E Cosgrove; Trish M Perl; Amy B Curtis; Jerome L Tokars; Daniel J Diekema; John A Jernigan; Virginia L Hinrichsen; Deborah S Yokoe; Richard Platt
Improving the assessment of vancomycin-resistant enterococci by routine screening.
The Journal of infectious diseases 2007;195(3):339-46.
2007: Susan S Huang; Sheryl L Rifas-Shiman; David K Warren; Victoria J Fraser; Michael W Climo; Edward S Wong; Sara E Cosgrove; Trish M Perl; Jean M Pottinger; Loreen A Herwaldt; John A Jernigan; Jerome L Tokars; Daniel J Diekema; Virginia L Hinrichsen; Deborah S Yokoe; Richard Platt
Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units.
The Journal of infectious diseases 2007;195(3):330-8.
2007: Michael A Pfaller; Daniel J Diekema
Epidemiology of invasive candidiasis: a persistent public health problem.
Clinical microbiology reviews 2007;20(1):133-63.
2007: Michael A Pfaller; Shawn A Messer; Linda Boyken; Cassie Rice; Shailesh Tendolkar; Richard J Hollis; Daniel J Diekema
Use of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of Candida spp. Tested by clinical and laboratory standards institute-recommended broth microdilution methods.
Journal of clinical microbiology 2007;45(1):70-5.
2006: Michael A Pfaller; Daniel J Diekema; A L Colombo; C Kibbler; K P Ng; DL Gibbs; VA Newell
Candida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.
Journal of clinical microbiology 2006;44(10):3578-82.
2006: Michael A Pfaller; Daniel J Diekema; M Mendez; C Kibbler; P Erzsebet; S-C Chang; DL Gibbs; VA Newell
Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.
Journal of clinical microbiology 2006;44(10):3551-6.
2006: Michael A Pfaller; Linda Boyken; Richard J Hollis; Shawn A Messer; Shailesh Tendolkar; Daniel J Diekema
Global surveillance of in vitro activity of micafungin against Candida: a comparison with caspofungin by CLSI-recommended methods.
Journal of clinical microbiology 2006;44(10):3533-8.
2006: Bryndis Sigurdardottir; Jeffery Vande Berg; Jianfang Hu; Josiah Alamu; louise-anne mcnutt; Daniel J Diekema; Loreen A Herwaldt
Descriptive epidemiology and case-control study of patients colonized with vancomycin-resistant enterococcus and methicillin-resistant Staphylococcus aureus.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2006;27(9):913-9.
2006: David K Warren; Sara E Cosgrove; Daniel J Diekema; Gianna Zuccotti; Michael W Climo; Maureen K Bolon; Jerome I Tokars; Gary A Noskin; Edward S Wong; Kent A Sepkowitz; Loreen A Herwaldt; Trish M Perl; Steven L Solomon; Victoria J Fraser
A multicenter intervention to prevent catheter-associated bloodstream infections.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2006;27(7):662-9.
2006: Gregory T Siwek; Michael A Pfaller; Philip M Polgreen; Sandra Cobb; Peter Hoth; Margarida Magalheas-Silverman; Daniel J Diekema
Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis.
Diagnostic microbiology and infectious disease 2006;55(3):209-12.
2006: Susan E Beekmann; Daniel J Diekema; Kris P Heilmann; Sandra S Richter; G V Doern
Macrolide use identified as risk factor for macrolide-resistant Streptococcus pneumoniae in a 17-center case-control study.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2006;25(5):335-9.
2006: Michael A Pfaller; Daniel J Diekema; Daniel J Sheehan
Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing.
Clinical microbiology reviews 2006;19(2):435-47.
2006: Philip M Polgreen; Susan E Beekmann; Yi Yi Chen; G V Doern; Michael A Pfaller; Angela B Brueggemann; Loreen A Herwaldt; Daniel J Diekema
Epidemiology of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in a rural state.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2006;27(3):252-6.
2006: Michael A Pfaller; Daniel J Diekema; John H Rex; Ana Espinel-Ingroff; E M Johnson; D Andes; V Chaturvedi; Mahmoud A Ghannoum; F C Odds; Michael G Rinaldi; Daniel J Sheehan; P Troke; THOMAS WALSH; D W Warnock
Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints.
Journal of clinical microbiology 2006;44(3):819-26.
2006: Michael A Pfaller; Linda Boyken; Richard J Hollis; Shawn A Messer; Shailesh Tendolkar; Daniel J Diekema
In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance.
Journal of clinical microbiology 2006;44(3):760-3.
2006: Shawn A Messer; Daniel J Diekema; Linda Boyken; Shailesh Tendolkar; Richard J Hollis; Michael A Pfaller
Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
Journal of clinical microbiology 2006;44(2):324-6.
2006: Philip M Polgreen; Jean M Pottinger; Linnea Polgreen; Daniel J Diekema; Loreen A Herwaldt
Influenza vaccination rates, feedback and the Hawthorne effect.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2006;27(1):98-9.
2006: Philip M Polgreen; Daniel J Diekema; Jeff Vandeberg; R Todd Wiblin; Yi Yi Chen; Sherry David; Dianne Rasmus; Nicole Gerdts; Angelena Ross; Louis Katz; Loreen A Herwaldt
Risk factors for groin wound infection after femoral artery catheterization: a case-control study.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2006;27(1):34-7.
2005: Michael A Pfaller; Daniel J Diekema; Michael G Rinaldi; R Barnes; B Hu; A V Veselov; N Tiraboschi; E Nagy; DL Gibbs
Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing.
Journal of clinical microbiology 2005;43(12):5848-59.
2005: Michael A Pfaller; Linda Boyken; Richard J Hollis; Shawn A Messer; Shailesh Tendolkar; Daniel J Diekema
In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole.
Journal of clinical microbiology 2005;43(11):5425-7.
2005: Michael A Pfaller; Daniel J Diekema; Linda Boyken; Shawn A Messer; Shailesh Tendolkar; Richard J Hollis; B P Goldstein
Effectiveness of anidulafungin in eradicating Candida species in invasive candidiasis.
Antimicrobial agents and chemotherapy 2005;49(11):4795-7.
2005: Michael A Pfaller; Linda Boyken; Shawn A Messer; Shailesh Tendolkar; Richard J Hollis; Daniel J Diekema
Comparison of results of voriconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program.
Journal of clinical microbiology 2005;43(10):5208-13.
2005: Michael A Pfaller; Linda Boyken; Richard J Hollis; Shawn A Messer; Shailesh Tendolkar; Daniel J Diekema
In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species to itraconazole: global survey of 9,359 isolates tested by clinical and laboratory standards institute broth microdilution methods.
Journal of clinical microbiology 2005;43(8):3807-10.
2005: Erika J Ernst; George Raley; Loreen A Herwaldt; Daniel J Diekema
Importance of control group selection for evaluating antimicrobial use as a risk factor for methicillin-resistant Staphylococcus aureus bacteremia.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2005;26(7):634-7.
2005: Susan E Beekmann; Daniel J Diekema; G V Doern
Determining the clinical significance of coagulase-negative staphylococci isolated from blood cultures.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2005;26(6):559-66.
2005: Michael A Pfaller; Shawn A Messer; Linda Boyken; Cassie Rice; Shailesh Tendolkar; Richard J Hollis; G V Doern; Daniel J Diekema
Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004).
Journal of clinical microbiology 2005;43(5):2163-7.
2005: Sandra S Richter; Rudolph P Galask; Shawn A Messer; Richard J Hollis; Daniel J Diekema; Michael A Pfaller
Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases.
Journal of clinical microbiology 2005;43(5):2155-62.
2005: Michael A Pfaller; Daniel J Diekema
Unusual fungal and pseudofungal infections of humans.
Journal of clinical microbiology 2005;43(4):1495-504.
2005: Stephen D Flach; Daniel J Diekema; Jon W Yankey; Bonnie J BootsMiller; Thomas E Vaughn; Erika J Ernst; Marcia M Ward; Bradley Doebbeling
Variation in the use of procedures to monitor antimicrobial resistance in U.S. hospitals.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2005;26(1):31-8.
2005: Marcia M Ward; Daniel J Diekema; Jon W Yankey; Thomas E Vaughn; Bonnie J BootsMiller; Jane F Pendergast; Bradley Doebbeling
Implementation of strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in U.S. hospitals.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2005;26(1):21-30.
2005: Daniel J Diekema; B Petroelje; Shawn A Messer; Richard J Hollis; Michael A Pfaller
Activities of available and investigational antifungal agents against rhodotorula species.
Journal of clinical microbiology 2005;43(1):476-8.
2004: Deborah S Yokoe; Gary A Noskin; Susan M Cunnigham; Gianna Zuccotti; Theresa Plaskett; Victoria J Fraser; Margaret A Olsen; Jerome I Tokars; Steven Solomon; Trish M Perl; Sara E Cosgrove; Richard S Tilson; Maurice Greenbaum; David C Hooper; Kenneth E Sands; John Tully; Daniel J Diekema; Edward S Wong; Michael W Climo; Loreen A Herwaldt; Richard Platt
Enhanced identification of postoperative infections among inpatients.
Emerging infectious diseases 2004;10(11):1924-30.
2004: Michael A Pfaller; Linda Boyken; Shawn A Messer; Shailesh Tendolkar; Richard J Hollis; Daniel J Diekema
Evaluation of the etest method using Mueller-Hinton agar with glucose and methylene blue for determining amphotericin B MICs for 4,936 clinical isolates of Candida species.
Journal of clinical microbiology 2004;42(11):4977-9.
2004: Michael A Pfaller; Linda Boyken; Richard J Hollis; Shawn A Messer; Shailesh Tendolkar; Daniel J Diekema
Clinical evaluation of a dried commercially prepared microdilution panel for antifungal susceptibility testing of five antifungal agents against Candida spp. and Cryptococcus neoformans.
Diagnostic microbiology and infectious disease 2004;50(2):113-7.
2004: Michael A Pfaller; Daniel J Diekema
Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.
Journal of clinical microbiology 2004;42(10):4419-31.
2004: Greg T Siwek; Kirsty J Dodgson; Margarida De Magalhaes-Silverman; Luther A Bartelt; Sara B Kilborn; Peter L Hoth; Daniel J Diekema; Michael A Pfaller
Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(4):584-7.
2004: Michael A Pfaller; K C Hazen; Shawn A Messer; Linda Boyken; Shailesh Tendolkar; Richard J Hollis; Daniel J Diekema
Comparison of results of fluconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program.
Journal of clinical microbiology 2004;42(8):3607-12.
2004: Michael A Pfaller; Shawn A Messer; Linda Boyken; Shailesh Tendolkar; Richard J Hollis; Daniel J Diekema
Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002.
Journal of clinical microbiology 2004;42(7):3142-6.
2004: Michael A Pfaller; Shawn A Messer; Linda Boyken; Cassie Rice; Shailesh Tendolkar; Richard J Hollis; Daniel J Diekema
Cross-resistance between fluconazole and ravuconazole and the use of fluconazole as a surrogate marker to predict susceptibility and resistance to ravuconazole among 12,796 clinical isolates of Candida spp.
Journal of clinical microbiology 2004;42(7):3137-41.
2004: Michael A Pfaller; Shawn A Messer; Linda Boyken; Cassie Rice; Shailesh Tendolkar; Richard J Hollis; Daniel J Diekema
Further standardization of broth microdilution methodology for in vitro susceptibility testing of caspofungin against Candida species by use of an international collection of more than 3,000 clinical isolates.
Journal of clinical microbiology 2004;42(7):3117-9.
2004: Daniel J Diekema; Kirsty J Dodgson; Bryndis Sigurdardottir; Michael A Pfaller
Rapid detection of antimicrobial-resistant organism carriage: an unmet clinical need.
Journal of clinical microbiology 2004;42(7):2879-83.
2004: Erika J Ernst; Daniel J Diekema; Bonnie J BootsMiller; Thomas E Vaughn; Jon W Yankey; Stephen D Flach; Marcia M Ward; Carrie L J Franciscus; Elise Acosta; Michael A Pfaller; Bradley Doebbeling
Are United States hospitals following national guidelines for the analysis and presentation of cumulative antimicrobial susceptibility data?
Diagnostic microbiology and infectious disease 2004;49(2):141-5.
2004: Philip M Polgreen; Shawn L Fultz; A C Justice; Joseph H Wagner; Daniel J Diekema; L Rabeneck; Sherman Weissman; Jack T Stapleton
Association of hypocholesterolaemia with hepatitis C virus infection in HIV-infected people.
HIV medicine 2004;5(3):144-50.
2004: Daniel J Diekema; Kathleen Lee; Patti Raney; Loreen A Herwaldt; G V Doern; Fred C Tenover
Accuracy and appropriateness of antimicrobial susceptibility test reporting for bacteria isolated from blood cultures.
Journal of clinical microbiology 2004;42(5):2258-60.
2004: Michael A Pfaller; Shawn A Messer; Linda Boyken; Richard J Hollis; Cassie Rice; Shailesh Tendolkar; Daniel J Diekema
In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program.
Diagnostic microbiology and infectious disease 2004;48(3):201-5.
2004: Michael A Pfaller; Linda Boyken; Shawn A Messer; Richard J Hollis; Daniel J Diekema
Stability of Mueller-Hinton agar supplemented with glucose and methylene blue for disk diffusion testing of fluconazole and voriconazole.
Journal of clinical microbiology 2004;42(3):1288-9.
2004: Michael A Pfaller; Daniel J Diekema
Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2004;10 Suppl 1():11-23.
2004: Michael A Pfaller; Daniel J Diekema; Shawn A Messer; Linda Boyken; Richard J Hollis; Ronald Jones
In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents.
Diagnostic microbiology and infectious disease 2004;48(2):101-5.
2004: Michael A Pfaller; Shawn A Messer; Linda Boyken; Cassie Rice; Shailesh Tendolkar; Richard J Hollis; Daniel J Diekema
Evaluation of the NCCLS M44-P disk diffusion method for determining susceptibilities of 276 clinical isolates of Cryptococcus neoformans to fluconazole.
Journal of clinical microbiology 2004;42(1):380-3.
2004: Daniel J Diekema; Bonnie J BootsMiller; Thomas E Vaughn; Robert F Woolson; Jon W Yankey; Erika J Ernst; Stephen D Flach; Marcia M Ward; Carrie L J Franciscus; Michael A Pfaller; Bradley Doebbeling
Antimicrobial resistance trends and outbreak frequency in United States hospitals.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(1):78-85.
2003: Michael A Pfaller; Shawn A Messer; Linda Boyken; Cassie Rice; Shailesh Tendolkar; Richard J Hollis; Daniel J Diekema
Caspofungin activity against clinical isolates of fluconazole-resistant Candida.
Journal of clinical microbiology 2003;41(12):5729-31.
2003: Daniel J Diekema; Susan E Beekmann; Kimberle C Chapin; K A Morel; Erik L Munson; G V Doern
Epidemiology and outcome of nosocomial and community-onset bloodstream infection.
Journal of clinical microbiology 2003;41(8):3655-60.
2003: Daniel J Diekema; Shawn A Messer; Richard J Hollis; Ronald Jones; Michael A Pfaller
Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi.
Journal of clinical microbiology 2003;41(8):3623-6.
2003: Susan E Beekmann; Daniel J Diekema; Kimberle C Chapin; G V Doern
Effects of rapid detection of bloodstream infections on length of hospitalization and hospital charges.
Journal of clinical microbiology 2003;41(7):3119-25.
2003: Janet I Andrews; Daniel J Diekema; Jerome Yankowitz
Prenatal testing for infectious disease.
Clinics in laboratory medicine 2003;23(2):295-315, viii.
2003: Daniel J Diekema; Janet I Andrews; Holly Huynh; Paul R Rhomberg; Stella R Doktor; Jill Beyer; Virginia D Shortridge; Robert K Flamm; Ronald Jones; Michael A Pfaller
Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococci.
Journal of clinical microbiology 2003;41(6):2659-61.
2003: Michael A Pfaller; Shawn A Messer; Linda Boyken; Shailesh Tendolkar; Richard J Hollis; Daniel J Diekema
Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location.
Journal of clinical microbiology 2003;41(5):2176-9.
2003: Michael A Pfaller; Daniel J Diekema; Linda Boyken; Shawn A Messer; Shailesh Tendolkar; Richard J Hollis
Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazole.
Journal of clinical microbiology 2003;41(5):1875-80.
2003: Michael A Pfaller; Shawn A Messer; Linda Boyken; Richard J Hollis; Daniel J Diekema
In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference M38-A microdilution methods for determining posaconazole MICs.
Diagnostic microbiology and infectious disease 2003;45(4):241-4.
2003: Michael A Pfaller; Daniel J Diekema; Shawn A Messer; Linda Boyken; Richard J Hollis
Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001.
Journal of clinical microbiology 2003;41(4):1440-6.
2003: J B Pfaller; Shawn A Messer; Richard J Hollis; Daniel J Diekema; Michael A Pfaller
In vitro susceptibility testing of Aspergillus spp.: comparison of Etest and reference microdilution methods for determining voriconazole and itraconazole MICs.
Journal of clinical microbiology 2003;41(3):1126-9.
2003: M J Maxwell; Shawn A Messer; Richard J Hollis; Linda Boyken; Shailesh Tendolkar; Daniel J Diekema; Michael A Pfaller
Evaluation of Etest method for determining fluconazole and voriconazole MICs for 279 clinical isolates of Candida species infrequently isolated from blood.
Journal of clinical microbiology 2003;41(3):1087-90.
2003: Michael A Pfaller; Daniel J Diekema; Shawn A Messer; Richard J Hollis; Ronald Jones
In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolates.
Antimicrobial agents and chemotherapy 2003;47(3):1068-71.
2003: Sandra S Richter; Daniel J Diekema; Kris P Heilmann; Laurel S Almer; Virginia D Shortridge; Rod Zeitler; Robert K Flamm; G V Doern
Fluoroquinolone resistance in Streptococcus pyogenes.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(3):380-3.
2003: Erik L Munson; Daniel J Diekema; Susan E Beekmann; Kimberle C Chapin; G V Doern
Detection and treatment of bloodstream infection: laboratory reporting and antimicrobial management.
Journal of clinical microbiology 2003;41(1):495-7.
2003: M J Maxwell; Shawn A Messer; Richard J Hollis; Daniel J Diekema; Michael A Pfaller
Evaluation of Etest method for determining voriconazole and amphotericin B MICs for 162 clinical isolates of Cryptococcus neoformans.
Journal of clinical microbiology 2003;41(1):97-9.
2003: Michael A Pfaller; Daniel J Diekema; Shawn A Messer; Linda Boyken; Richard J Hollis; Ronald Jones
In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood.
Journal of clinical microbiology 2003;41(1):78-83.
2002: Daniel J Diekema; Michael A Pfaller; Ronald Jones
Age-related trends in pathogen frequency and antimicrobial susceptibility of bloodstream isolates in North America: SENTRY Antimicrobial Surveillance Program, 1997-2000.
International journal of antimicrobial agents 2002;20(6):412-8.
2002: Michael A Pfaller; Shawn A Messer; Linda Boyken; Holly Huynh; Richard J Hollis; Daniel J Diekema
In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods.
Antimicrobial agents and chemotherapy 2002;46(11):3518-21.
2002: Michael A Pfaller; Daniel J Diekema
Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility.
Journal of clinical microbiology 2002;40(10):3551-7.
2002: Sandra S Richter; Susan E Beekmann; J L Croco; Daniel J Diekema; FP Koontz; Michael A Pfaller; G V Doern
Minimizing the workup of blood culture contaminants: implementation and evaluation of a laboratory-based algorithm.
Journal of clinical microbiology 2002;40(7):2437-44.
2002: Michael A Pfaller; Shawn A Messer; Richard J Hollis; Ronald Jones; Daniel J Diekema
In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.
Antimicrobial agents and chemotherapy 2002;46(6):1723-7.
2002: Michael A Pfaller; Daniel J Diekema; Shawn A Messer; Linda Boyken; Holly Huynh; Richard J Hollis
Clinical evaluation of a frozen commercially prepared microdilution panel for antifungal susceptibility testing of seven antifungal agents, including the new triazoles posaconazole, ravuconazole, and voriconazole.
Journal of clinical microbiology 2002;40(5):1694-7.
2002: Daniel J Diekema; Shawn A Messer; Angela B Brueggemann; Stacy Coffman; G V Doern; Loreen A Herwaldt; Michael A Pfaller
Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study.
Journal of clinical microbiology 2002;40(4):1298-302.
2002: Michael A Pfaller; Daniel J Diekema; Ronald Jones; Shawn A Messer; Richard J Hollis
Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000.
Journal of clinical microbiology 2002;40(3):852-6.
2001: Toshiaki Yamazumi; Itaru Furuta; Daniel J Diekema; Michael A Pfaller; Ronald Jones
Comparison of the Vitek gram-positive susceptibility 106 card, the MRSA-Screen latex agglutination test, and mecA analysis for detecting oxacillin resistance in a geographically diverse collection of clinical isolates of coagulase-negative staphylococci.
Journal of clinical microbiology 2001;39(10):3633-6.
2001: Daniel J Diekema; Michael A Pfaller; F J Schmitz; Jorgelina Smayevsky; J Bell; Ronald Jones; M Beach
Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32 Suppl 2():S114-32.
2001: Daniel J Diekema; Mondell L Beach; Michael A Pfaller; Ronald Jones
Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2001;7(3):152-7.
2001: Toshiaki Yamazumi; SA Marshall; Werner W Wilke; Daniel J Diekema; Michael A Pfaller; Ronald Jones
Comparison of the Vitek Gram-Positive Susceptibility 106 card and the MRSA-screen latex agglutination test for determining oxacillin resistance in clinical bloodstream isolates of Staphylococcus aureus.
Journal of clinical microbiology 2001;39(1):53-6.
2000: Janet I Andrews; Daniel J Diekema; Stephen K Hunter; Paul R Rhomberg; Michael A Pfaller; Ronald Jones; G V Doern
Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere.
American journal of obstetrics and gynecology 2000;183(4):859-62.
2000: Daniel J Diekema; Angela B Brueggemann; G V Doern
Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae.
Emerging infectious diseases 2000;6(5):552-6.
2000: Daniel J Diekema; Michael A Pfaller; Ronald Jones; G V Doern; KC Kugler; Mondell L Beach; Helio S Sader
Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group.
International journal of antimicrobial agents 2000;13(4):257-71.
2000: Daniel J Diekema; Michael A Pfaller; J Turnidge; Jan Verhoef; J Bell; A C Fluit; G V Doern; Ronald Jones
Genetic relatedness of multidrug-resistant, methicillin (oxacillin)-resistant Staphylococcus aureus bloodstream isolates from SENTRY Antimicrobial Resistance Surveillance Centers worldwide, 1998.
Microbial drug resistance (Larchmont, N.Y.) 2000;6(3):213-21.
1999: Daniel J Diekema; Michael A Pfaller; Ronald Jones; G V Doern; Patricia L Winokur; Ana Gales; Helio S Sader; KC Kugler; M Beach
Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;29(3):595-607.
1999: Lalitagauri M Deshpande; Daniel J Diekema; Ronald Jones
Comparative activity of clinafloxacin and nine other compounds tested against 2000 contemporary clinical isolates from patients in United States hospitals.
Diagnostic microbiology and infectious disease 1999;35(1):81-8.
1999: Daniel J Diekema; Michael A Pfaller; Shawn A Messer; AK Houston; Richard J Hollis; G V Doern; Ronald Jones
In vitro activities of BMS-207147 against over 600 contemporary clinical bloodstream isolates of Candida species from the SENTRY Antimicrobial Surveillance Program in North America and Latin America.
Antimicrobial agents and chemotherapy 1999;43(9):2236-9.
1999: Daniel J Diekema; Ronald Jones; K V Rolston
Antimicrobial activity of gatifloxacin compared to seven other compounds tested against gram-positive organisms isolated at 10 cancer-treatment centers.
Diagnostic microbiology and infectious disease 1999;34(1):37-43.
1999: Daniel J Diekema; Stacy Coffman; SA Marshall; Mondell L Beach; K V Rolston; Ronald Jones
Comparison of activities of broad-spectrum beta-lactam compounds against 1,128 gram-positive cocci recently isolated in cancer treatment centers.
Antimicrobial agents and chemotherapy 1999;43(4):940-3.
1997: Daniel J Diekema; Shawn A Messer; Richard J Hollis; Richard P Wenzel; Michael A Pfaller
An outbreak of Candida parapsilosis prosthetic valve endocarditis.
Diagnostic microbiology and infectious disease 1997;29(3):147-53.
1997: Daniel J Diekema; J Barr; Linda Boyken; BJ Buschelman; Ronald Jones; Michael A Pfaller; Loreen A Herwaldt
A cluster of serious Escherichia coli infections in a neonatal intensive-care unit.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1997;18(11):774-6.
1996: Daniel J Diekema; Mark A Albanese; Peter Densen; Bradley Doebbeling
Student health policies of U.S. medical schools.
Academic medicine : journal of the Association of American Medical Colleges 1996;71(10):1090-2.
1996: Daniel J Diekema; Mark A Albanese; S S Schuldt; Bradley Doebbeling
Blood and body fluid exposures during clinical training: relation to knowledge of universal precautions.
Journal of general internal medicine 1996;11(2):109-11.
1995: Daniel J Diekema; S S Schuldt; Mark A Albanese; Bradley Doebbeling
Universal precautions training of preclinical students: impact on knowledge, attitudes, and compliance.
Preventive medicine 1995;24(6):580-5.
1995: Daniel J Diekema; Bradley Doebbeling
Employee health and infection control.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1995;16(5):292-301.
1995: Daniel J Diekema; Kristi J Ferguson; Bradley Doebbeling
Motivation for hepatitis B vaccine acceptance among medical and physician assistant students.
Journal of general internal medicine 1995;10(1):1-6.